Skip to content

BioMarin Pharmaceutical - Prosensa

BioMarin Pharmaceutical acquires Prosensa

Announced: November 24, 2014

Type:           Acquisition
Disposition: Separate Entity
Terms:         Cash & Stock
Status:         Complete

Amount:       $ 840,000,000

Acquisition News

Add News

Date Title
There are no news.

BioMarin Pharmaceutical Other Acquisitions

Add Acquisition

Date Acquired Amount
Jan 07, 2013
Zacharon Pharmaceuticals
Undisclosed amount
Aug 18, 2010
Zystor
$ 115,000,000
Feb 10, 2010
LEAD Therapeutics
$ 97,000,000
Oct 26, 2009
Huxley Pharmaceuticals
Undisclosed amount
Feb 07, 2002
Glyko Biomedical
Undisclosed amount
View more acquisitions »